Gotham Asset Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$622K Buy
3,220
+51
+2% +$6.3K ﹤0.01% 1542
2026
Q2
$326K Buy
+3,169
New +$206K ﹤0.01% 1623
2025
Q1
– Sell
-16,925
Closed -$787K – 1663
2024
Q4
$787K Sell
16,925
-10,813
-39% -$489K 0.01% 985
2024
Q3
$1.25M Sell
27,738
-51,314
-65% -$2.44M 0.01% 857
2024
Q2
$3.9M Buy
79,052
+18,180
+30% +$741K 0.05% 494
2024
Q1
$2.09M Buy
60,872
+5,793
+11% +$209K 0.03% 638
2023
Q4
$2.03M Buy
55,079
+12,481
+29% +$289K 0.04% 602
2023
Q3
$863K Buy
42,598
+30,537
+253% +$671K 0.02% 827
2023
Q2
$247K Buy
+12,061
New +$181K 0.01% 1178

Other funds holding TWST

Gotham Asset Management's TWST Position: Q3 2026 in Review

Gotham Asset Management increased its Twist Bioscience (TWST) stake by 1.6% in Q3 2026, buying an estimated $6.3K and bringing the position to 3,220 shares worth $622K. The position accounts for ﹤0.01% of the portfolio, ranked #1542.

Gotham Asset Management first reported a position in TWST in Q2 2023 and has held it in 9 quarters since. The position peaked at $3.9M in Q2 2024. 435 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Gotham Asset Management held 3,220 shares of Twist Bioscience worth $622K as of Q3 2026.
  • Gotham Asset Management bought 51 Twist Bioscience shares in Q3 2026, an estimated $6.3K.
  • Twist Bioscience made up ﹤0.01% of Gotham Asset Management's portfolio in Q3 2026, its #1542 holding.
  • Gotham Asset Management first reported a position in Twist Bioscience in Q2 2023 and has held it in 9 quarters since.
  • Gotham Asset Management's Twist Bioscience position peaked at $3.9M in Q2 2024.
  • 435 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.